Onternabez: Difference between revisions
Content deleted Content added
m →References: clean up and Typo fixing using AWB |
|||
| Line 58: | Line 58: | ||
{{cannabinoid-stub}} |
{{cannabinoid-stub}} |
||
[[it:HU-308]] |
|||
[[sr:HU-308]] |
|||
Revision as of 10:03, 11 March 2013
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C27H43O2 |
| Molar mass | 414.621 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
HU-308 is a drug that acts as a cannabinoid agonist. It is highly selective for the CB2 receptor subtype, with a selectivity of over 5000x for CB2 vs CB1.[1] The synthesis and characterization took place in the laboratory of Prof. Mechoulam at the Hebrew University of Jerusalem in the late 1990s. It has analgesic effects,[2] promotes proliferation of neural stem cells,[3] and protects both liver and blood vessel tissues against oxidative stress via inhibition of TNF-α.[4][5]
See also
References
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 10588688, please use {{cite journal}} with
|pmid=10588688instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16316653, please use {{cite journal}} with
|pmid=16316653instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17015409, please use {{cite journal}} with
|pmid=17015409instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17652447, please use {{cite journal}} with
|pmid=17652447instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17660390, please use {{cite journal}} with
|pmid=17660390instead.
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |